Polyreactive antibodies in the circulation of patients with systemic lupus erythematosus

Abstract

Get full access to this article

View all access options for this article.

References

Zhou

Tzioufas

Notkins

. Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells. J Autoimmun 2007; 29: 219–228.

Zhou

Wild

Xiong

. Polyreactive antibodies plus complement enhance the phagocytosis of cells made apoptotic by UV-light or HIV. Sci Rep 2013; 3: 2271–2271.

Notkins

. Polyreactivity of antibody molecules. Trends Immunol 2004; 25: 174–179.

Gunti S, Notkins AL. Polyreactive antibodies: Function and quantification. J Infect Dis 2015; 212 Suppl 1; S42–S46.

Berneman

Guilbert

Eschrich

Avrameas

. IgG auto- and polyreactivities of normal human sera. Mol Immunol 1993; 30: 1499–1510.

Matsiota

Druet

Dosquet

Guilbert

Avrameas

. Natural autoantibodies in systemic lupus erythematosus. Clin Exp Immunol 1987; 69: 79–88.

Chou

Fogelstrand

Hartvigsen

. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest 2009; 119: 1335–1349.

Marshak-Rothstein

. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006; 6: 823–835.

Gronwall

Akhter

Burlingame

Petri

Silverman

. IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE. Clin Immunol 2012; 142: 390–398.